ZSTK

ZeroStack Corp. Common Stock (ZSTK)

Stock · NASDAQ · Health Care

$4.16as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

ZeroStack Corp. noted among health‑care stocks moving in pre‑market. ZeroStack Corp. appeared in a Benzinga list of health‑care stocks that showed price movement in Friday’s pre‑market session. The mention highlights short‑term interest in the stock ahead of regular trading. The stock is currently near its $1.70 support level, with an RSI around the mid‑40s.

Active signals

Support level
$1.7
Industry
Other Pharmaceuticals

What ZSTK's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakout22-11.6%41%
Bollinger Band Breakdown18+2.6%56%
Volume Spike12-18.1%17%
200-Day Moving Average TouchActive now5-16.0%40%
Any 20-session window (baseline)-10.9%37%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About ZSTK

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti…

Sector
Health Care
Industry
Other Pharmaceuticals
Employees
21

Fundamentals

1-day range
$4$4.25
Market cap
$30.78M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-27.13
Dividend yield
—
Beta
2.10
Avg. volume
493.2K
52-week range
$1.32$20.45

How ZeroStack Corp. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$35.68MCost of Revenue$34.03M (95%)SG&A$1.39M (4%)Other$199.0K (1%)Tax$59.0K (0%)ZSTK

Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub

Gross Profit$1.65M(5%)
Operating Income-$154.65M(-433%)

Forecasts

1 analyst ratings

Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$11
+164.4%
Median
$11
+164.4%
Low
$11
+164.4%

ZeroStack Corp. Common Stock Competitors

Chosen by industry and closest market cap.

  • ZSTK
    ZeroStack Corp. Common Stock
    $4
    ▼ 5.21%
    Market cap $30.78MP/E —
    $1.32$20.45
  • HKPD
    Cellyan Biotechnology Co. Ltd Class A Ordinary Shares
    $0.11
    ▲ 0.00%
    Market cap $16.93MP/E —
    $0.095$1.72
  • COSM
    Cosmos Health Inc. Common Stock
    $0.331
    ▼ 1.49%
    Market cap $13.72MP/E —
    $0.1616$1.26
  • MEDS
    DataMeds AI Inc. Common Stock
    $2.63
    ▼ 7.72%
    Market cap $7.52MP/E —
    $0.8225$12.31
  • NUS
    Nu Skin Enterprises Inc. Common Stock
    $5.14
    ▼ 1.34%
    Market cap $251.98MP/E 4.30
    $4.45$11.67
  • HLF
    Herbalife Ltd. Common Shares
    $14.6
    ▲ 0.21%
    Market cap $1.19BP/E 9.24
    $7.56$20.4
  • CAH
    Cardinal Health Inc. Common Stock
    $254.06
    ▲ 0.14%
    Market cap $55.66BP/E 33.97
    $152.46$258.3

P/E shows — for peers not currently carrying a live signal of their own.

Insider Activity

Insider Actions →
Acquired
11.91M
Disposed
1.0K

Institutional Ownership

March 31, 2026

Total shares held
51.6K
Total value held
$319.1K
Institutional holders
9
Top holders this quarter
  • Unknown25.4K
  • Unknown25.3K
  • Unknown666
  • Unknown173
  • Unknown12
  • Unknown12
  • Unknown12
  • Unknown12
  • Unknown1

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.